Latest filing published 28 Jan 2016 for REPROS THERAPEUTICS INC., €8,634.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
J. F. Wernicke: trading record in brief
This profile gathers the share dealings of J. F. Wernicke in Repros Therapeutics Inc. In total, 3 filings cover trades dated 25 January 2016.
On the market, this insider has only ever bought: 3 purchases, €10k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €1,025. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 28 January 2016: an open-market purchase of €8,634, in Repros Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to J. F. Wernicke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,400 shares@ US$1.1183.8% of flowCommon StockSEC:0001144204-16-077573:2Canonical exit: 24 Apr 2016 (T+90)
- 980 shares@ US$1.1310.0% of flowCommon StockSEC:0001144204-16-077573:1Canonical exit: 24 Apr 2016 (T+90)
- 620 shares@ US$1.126.2% of flowCommon StockSEC:0001144204-16-077573:0Canonical exit: 24 Apr 2016 (T+90)
3 of 3 declarations
